Danaher, Innovative Genomics Institute partner on CRISPR-based therapies
The Danaher-IGI Beacon for CRISPR Cures centre will use CRISPR-based gene editing technology to drive pre-clinical gene-editing therapies…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Jan 24
The Danaher-IGI Beacon for CRISPR Cures centre will use CRISPR-based gene editing technology to drive pre-clinical gene-editing therapies…
09 Jan 24
The collaboration is aimed at deepening comprehension of cell morphology, ultimately hastening the integration of AI-driven cellular analysis…
08 Jan 24
Both companies will work together to study potential vaccines for bacterial pathogens in AstraZeneca’s early Vaccines & Immune…
04 Jan 24
The deal combines Galapagos’ expertise in small molecule drug discovery and translational research along with BridGene’s proprietary IMTAC…
03 Jan 24
Voyager and Novartis Pharma will work on potential gene therapies for Huntington’s disease and spinal muscular atrophy using…
03 Jan 24
Apollo Therapeutics is a portfolio biopharmaceutical company focused on translating fundamental medical research into medicines
22 Dec 23
Both firms will use EVQLV's proprietary artificial intelligence-powered Antibody Design Engine to generate novel antibodies against multiple targets…
22 Dec 23
Through the new collaboration, ImmunoScape and EDDC will jointly develop novel off-the-shelf TCR-based bispecific molecules using ImmunoScape’s database…
21 Dec 23
Since its establishment in 2020, the Indiana-based biopharmaceutical company has raised a total of $157m funding, with $37m…
20 Dec 23
The joint research venture entitled, New Strategies to Engage Neutrophils in Solid Tumors, is intended to develop immunotherapies…